FR2453640A1 - Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine - Google Patents

Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine

Info

Publication number
FR2453640A1
FR2453640A1 FR7909268A FR7909268A FR2453640A1 FR 2453640 A1 FR2453640 A1 FR 2453640A1 FR 7909268 A FR7909268 A FR 7909268A FR 7909268 A FR7909268 A FR 7909268A FR 2453640 A1 FR2453640 A1 FR 2453640A1
Authority
FR
France
Prior art keywords
anionic
plasticiser
cationic
methacrylic acid
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7909268A
Other languages
English (en)
Other versions
FR2453640B1 (fr
Inventor
Hubert Armand
Roland Segonds
Pierre Lotteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labaz SA
Original Assignee
Labaz SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz SA filed Critical Labaz SA
Priority to FR7909268A priority Critical patent/FR2453640A1/fr
Publication of FR2453640A1 publication Critical patent/FR2453640A1/fr
Application granted granted Critical
Publication of FR2453640B1 publication Critical patent/FR2453640B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Abstract

L'INVENTION SE RAPPORTE A DES MICROGRANULES A LIBERATION PROGRAMMEE DANS LE TEMPS DE LEUR PRINCIPE ACTIF AINSI QU'AUX COMPOSITIONS THERAPEUTIQUES LES CONTENANT. LES MICROGRANULES SELON L'INVENTION SONT CONSTITUES: -D'UN SUPPORT DE MATIERE INACTIVE; -D'UN DEPOT DE PRINCIPE ACTIF REPRESENTE PAR LE METHANESULFONATE DE DIHYDROERGOTAMINE, CE DEPOT ETANT FIXE SUR LE SUPPORT; -D'UN FILM D'ENROBAGE FIXE SUR LE PRINCIPE ACTIF ET CONSTITUE D'UN MELANGE DE DEUX POLYMERES DE L'ACIDE METHACRYLIQUE A SAVOIR UN POLYMERE ANIONIQUE ET UN POLYMERE CATIONIQUE ET D'UN PLASTIFIANT. LES COMPOSITIONS THERAPEUTIQUES A USAGE ORAL SELON L'INVENTION CONTIENNENT DES MICROGRANULES A LIBERATION PROGRAMMEE COMME DECRITS CI-DESSUS ET EVENTUELLEMENT DES MICROGRANULES NEUTRES ETOU A LIBERATION IMMEDIATE.
FR7909268A 1979-04-12 1979-04-12 Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine Granted FR2453640A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7909268A FR2453640A1 (fr) 1979-04-12 1979-04-12 Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7909268A FR2453640A1 (fr) 1979-04-12 1979-04-12 Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine

Publications (2)

Publication Number Publication Date
FR2453640A1 true FR2453640A1 (fr) 1980-11-07
FR2453640B1 FR2453640B1 (fr) 1982-05-21

Family

ID=9224258

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7909268A Granted FR2453640A1 (fr) 1979-04-12 1979-04-12 Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine

Country Status (1)

Country Link
FR (1) FR2453640A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
FR2539989A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
US4726966A (en) * 1985-11-27 1988-02-23 Showa Shinyaku Co., Ltd. Preparation of coated granular ibuprofen microsphere
WO1995008323A1 (fr) * 1993-09-23 1995-03-30 Dr. Falk Pharma Gmbh Pellets de budesonide a liberation controlee et leur procede de preparation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
EP0036350A1 (fr) * 1980-03-03 1981-09-23 Pierre Fabre Medicament Composition pharmaceutique à activité régulatrice sur le tonus vasculaire
FR2539989A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
EP0117164A1 (fr) * 1983-01-28 1984-08-29 Elf Sanofi Médicament à libération programmée associant l'acide acétylsalicylique à la dihydroergotamine
US4726966A (en) * 1985-11-27 1988-02-23 Showa Shinyaku Co., Ltd. Preparation of coated granular ibuprofen microsphere
WO1995008323A1 (fr) * 1993-09-23 1995-03-30 Dr. Falk Pharma Gmbh Pellets de budesonide a liberation controlee et leur procede de preparation
US5932249A (en) * 1993-09-23 1999-08-03 Dr. Falk Pharma Gmbh Budesonide pellets with a controlled released pattern and process for producing the same

Also Published As

Publication number Publication date
FR2453640B1 (fr) 1982-05-21

Similar Documents

Publication Publication Date Title
RU92004344A (ru) Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, и способ их получения
NO156454C (no) Fremgangsmaate for aa anbringe et hydrofilt belegg paa en polymeroverflate, samt medisinsk artikkel med et saaledes fremstilt belegg
CA2074309A1 (fr) Formulations stabilisees a liberation controlee, presentant une couche de polymere acrylique
EP0259219A3 (fr) Comprimé à libération commandée
NO178136C (no) Framgangsmåte for framstilling av et preparat for styrt frigjöring av en farmasöytisk aktiv substans
ES2094431T3 (es) Microgranulos de pancreatina con un revestimiento resistente a los jugos gastricos.
CA2019410A1 (fr) Solution a base de polymere et mode d'utilisation connexe
NO155889C (no) Fremgangsmaate for aa anbringe et hydrofilt belegg paa en polymeroverflate, samt medisinsk artikkel med et slikt belegg
NO992994D0 (no) Legemidler mot hoste avlevert av ionebytterharpikser
CA2225096A1 (fr) Mode d'application de revetements liberant un medicament
ES8400029A1 (es) Procedimiento para la preparacion de una suspension hidroalcoholica.
ATE150963T1 (de) Kugelförmige granula mit kern sowie deren herstellung
WO1998058690A3 (fr) Hydrogel souple adhesif et revetements medicamenteux
EP0171528A3 (fr) Préparations pharmaceutiques à effet prolongé
FR2453640A1 (fr) Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine
EP0781549A3 (fr) Procédé de fabrication d'une préparation solide recouverte d'un enrobage sans solvant
FR2453642A1 (fr) Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2073007A5 (en) Immobielised active enzyme products
EP0371258A3 (fr) Substrats poreux, hydratés aux surfaces à base de polyacrylonitrile, tels que des dérivés en perles, leur procédé de préparation, et méthodes d'application
IL115450A (en) Process for coating powders with polymers
JPS56158712A (en) Oral microcapsule of active carbon
GB1504101A (en) Non-thrombogenic catheter
AU6285786A (en) Soluble acrylic copolymer containing carboxyl groups, its production process and coating agent on the basis of this acrylic copolymer
ES2054585A1 (es) Metodo para incrementar la produccion y calidad de la lana y el peso en vivo de corderos.
FR2453641A1 (fr) Compositions therapeutiques a usage oral et a liberation programmee l'oxalate de naftidrofuryl

Legal Events

Date Code Title Description
TP Transmission of property
CA Change of address
CD Change of name or company name
ST Notification of lapse